You must be signed in to set price alerts.
The IRB approved BlinkLab’s main FDA 510(k) trial phase, reduces regulatory risk, puts the company on the map and improves prospects for US market entry. This is super good news!6A1270553_BB1.pdf
There is a trade pending processing for this company.
Trades cannot be saved or cancelled while they are pending-processing.